Regeneron Strikes A CHORD With Deafness Gene Therapy
A very early success with a gene therapy for a rare form of deafness puts Regeneron ahead of Lilly and Sensorion.
A very early success with a gene therapy for a rare form of deafness puts Regeneron ahead of Lilly and Sensorion.